{"id":3305,"date":"2021-06-15T13:15:23","date_gmt":"2021-06-15T10:15:23","guid":{"rendered":"https:\/\/www.intheranostics.com\/prof\/?p=3305"},"modified":"2021-06-16T12:39:03","modified_gmt":"2021-06-16T09:39:03","slug":"lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi","status":"publish","type":"post","link":"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/","title":{"rendered":"Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00c7al\u0131\u015fmas\u0131"},"content":{"rendered":"<h3>Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00e7al\u0131\u015fmas\u0131nda metastatik kastrasyona diren\u00e7li prostat kanserli erkekler i\u00e7in genel sa\u011fkal\u0131m\u0131 ve radyolojik progresyonsuz sa\u011fkal\u0131m\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015ftiriyor.<\/h3>\n<p>VISION \u00e7al\u0131\u015fmas\u0131 sonu\u00e7lar\u0131 6 Haziran&#8217;da 2021 Amerikan Klinik Onkoloji Derne\u011fi (ASCO) Y\u0131ll\u0131k Toplant\u0131s\u0131 genel oturumunda sunuldu. Bildiride, ilerleyici PSMA \u2013 PET g\u00f6r\u00fcnt\u00fclemesi pozitif metastatik kastrasyona diren\u00e7li prostat kanseri (mCRPC) hastalar\u0131nda, hedefe y\u00f6nelik radyoligand tedavi olan Lutesyum-177 PSMA&#8217;n\u0131n en iyi bak\u0131m standard\u0131 (\u201cstandard of care\u201d) ile birlikte kullan\u0131m\u0131n\u0131n, tek ba\u015f\u0131na en iyi bak\u0131m standard\u0131na k\u0131yasla genel sa\u011fkal\u0131mda \u00f6nemli iyile\u015fme g\u00f6sterdi\u011fi duyuruldu.\u00a0<u><\/u><u><\/u><\/p>\n<p><u><\/u>\u00c7al\u0131\u015fma kollar\u0131 aras\u0131ndaki genel sa\u011fkal\u0131m fark\u0131n\u0131n istatistiksel olarak anlaml\u0131 (p&lt;0,001) bulundu\u011fu ara\u015ft\u0131rmada, yaln\u0131zca en iyi bak\u0131m standard\u0131 kolu (n=280) ile kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda Lutesyum-177 PSMA kolunda (n=551) \u00f6l\u00fcm riskinde %38 azalma saptand\u0131. Ayr\u0131ca, radyolojik progresyonsuz sa\u011fkal\u0131m i\u00e7in de, Lutesyum-177 PSMA uygulanan hastalarda, yaln\u0131zca en iyi bak\u0131m standard\u0131 alan kola k\u0131yasla, %60 risk azalmas\u0131 (p&lt;0,001) g\u00f6sterildi.<u><\/u><u><\/u><\/p>\n<p><u><\/u>\u00c7al\u0131\u015fman\u0131n Bilimsel Komitesine ba\u015fkanl\u0131k eden ve Memorial Sloan Kettering Kanser Merkezi&#8217;nde Genito\u00fcriner Onkoloji &#8211; Prostat Kanseri B\u00f6l\u00fcm Ba\u015fkan\u0131 olan Dr. Michael J. Morris, \u201c\u00c7a\u011fda\u015f hormonal tedaviler ve kemoterapi alt\u0131ndayken progresyon g\u00f6steren mCRPC hastalar\u0131nda \u00e7ok az anlaml\u0131 tedavi se\u00e7ene\u011fi vard\u0131r. Bu \u00e7al\u0131\u015fma, Lutesyum-177 PSMA&#8217;n\u0131n, mCRPC hasta grubunda klinik faydan\u0131n temel \u00f6l\u00e7\u00fctleri olan hastal\u0131k ilerlemesini iyile\u015ftirdi\u011fini ve sa\u011fkal\u0131m\u0131 uzatt\u0131\u011f\u0131n\u0131 g\u00f6sterdi. Bu grup hastalar i\u00e7in ek tedavi se\u00e7ene\u011fi sunan bu \u00e7al\u0131\u015fman\u0131n bir par\u00e7as\u0131 oldu\u011fum i\u00e7in minnettar\u0131m.\u201d dedi.<u><\/u><u><\/u><\/p>\n<p><u><\/u>Lutesyum-177 PSMA tedavisindeki bir sonraki hedef ise prostat kanserinin daha erken evrelerinde bu tedavinin klinik faydas\u0131n\u0131n ara\u015ft\u0131r\u0131lmas\u0131 oldu\u011fu bildirildi.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00e7al\u0131\u015fmas\u0131nda metastatik kastrasyona diren\u00e7li prostat kanserli erkekler i\u00e7in genel sa\u011fkal\u0131m\u0131 ve radyolojik progresyonsuz sa\u011fkal\u0131m\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015ftiriyor. VISION \u00e7al\u0131\u015fmas\u0131 sonu\u00e7lar\u0131 6 Haziran&#8217;da 2021 Amerikan Klinik Onkoloji Derne\u011fi (ASCO) Y\u0131ll\u0131k Toplant\u0131s\u0131 genel oturumunda sunuldu. Bildiride, ilerleyici PSMA \u2013 PET g\u00f6r\u00fcnt\u00fclemesi pozitif metastatik kastrasyona diren\u00e7li prostat kanseri (mCRPC) hastalar\u0131nda, hedefe y\u00f6nelik [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":3322,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[41],"tags":[42],"class_list":["post-3305","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lutesyum-177-psma","tag-lutesyum-177"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00c7al\u0131\u015fmas\u0131 - Prof intheranostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00c7al\u0131\u015fmas\u0131 - Prof intheranostics\" \/>\n<meta property=\"og:description\" content=\"Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00e7al\u0131\u015fmas\u0131nda metastatik kastrasyona diren\u00e7li prostat kanserli erkekler i\u00e7in genel sa\u011fkal\u0131m\u0131 ve radyolojik progresyonsuz sa\u011fkal\u0131m\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015ftiriyor. VISION \u00e7al\u0131\u015fmas\u0131 sonu\u00e7lar\u0131 6 Haziran&#8217;da 2021 Amerikan Klinik Onkoloji Derne\u011fi (ASCO) Y\u0131ll\u0131k Toplant\u0131s\u0131 genel oturumunda sunuldu. Bildiride, ilerleyici PSMA \u2013 PET g\u00f6r\u00fcnt\u00fclemesi pozitif metastatik kastrasyona diren\u00e7li prostat kanseri (mCRPC) hastalar\u0131nda, hedefe y\u00f6nelik [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/\" \/>\n<meta property=\"og:site_name\" content=\"Prof intheranostics\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-15T10:15:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-16T09:39:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.intheranostics.com\/prof\/wp-content\/uploads\/sites\/2\/2021\/06\/Intheranostis-prof-lutesyum-177-psma-research.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1999\" \/>\n\t<meta property=\"og:image:height\" content=\"1333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"faruk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"faruk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/\",\"url\":\"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/\",\"name\":\"Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00c7al\u0131\u015fmas\u0131 - Prof intheranostics\",\"isPartOf\":{\"@id\":\"https:\/\/www.intheranostics.com\/prof\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.intheranostics.com\/prof\/wp-content\/uploads\/sites\/2\/2021\/06\/Intheranostis-prof-lutesyum-177-psma-research.jpg\",\"datePublished\":\"2021-06-15T10:15:23+00:00\",\"dateModified\":\"2021-06-16T09:39:03+00:00\",\"author\":{\"@id\":\"https:\/\/www.intheranostics.com\/prof\/#\/schema\/person\/38ee8a4a3a1328e80b6475667e9cb9c4\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/#primaryimage\",\"url\":\"https:\/\/www.intheranostics.com\/prof\/wp-content\/uploads\/sites\/2\/2021\/06\/Intheranostis-prof-lutesyum-177-psma-research.jpg\",\"contentUrl\":\"https:\/\/www.intheranostics.com\/prof\/wp-content\/uploads\/sites\/2\/2021\/06\/Intheranostis-prof-lutesyum-177-psma-research.jpg\",\"width\":1999,\"height\":1333},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Ana sayfa\",\"item\":\"https:\/\/www.intheranostics.com\/prof\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00c7al\u0131\u015fmas\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.intheranostics.com\/prof\/#website\",\"url\":\"https:\/\/www.intheranostics.com\/prof\/\",\"name\":\"Prof intheranostics\",\"description\":\"Internal Radionuclide Diagnosis &amp; Therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.intheranostics.com\/prof\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.intheranostics.com\/prof\/#\/schema\/person\/38ee8a4a3a1328e80b6475667e9cb9c4\",\"name\":\"faruk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/www.intheranostics.com\/prof\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/526b11e80af0c3c187b5533b00ac60a0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/526b11e80af0c3c187b5533b00ac60a0?s=96&d=mm&r=g\",\"caption\":\"faruk\"},\"url\":\"https:\/\/www.intheranostics.com\/prof\/blog\/author\/faruk\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00c7al\u0131\u015fmas\u0131 - Prof intheranostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/","og_locale":"tr_TR","og_type":"article","og_title":"Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00c7al\u0131\u015fmas\u0131 - Prof intheranostics","og_description":"Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00e7al\u0131\u015fmas\u0131nda metastatik kastrasyona diren\u00e7li prostat kanserli erkekler i\u00e7in genel sa\u011fkal\u0131m\u0131 ve radyolojik progresyonsuz sa\u011fkal\u0131m\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015ftiriyor. VISION \u00e7al\u0131\u015fmas\u0131 sonu\u00e7lar\u0131 6 Haziran&#8217;da 2021 Amerikan Klinik Onkoloji Derne\u011fi (ASCO) Y\u0131ll\u0131k Toplant\u0131s\u0131 genel oturumunda sunuldu. Bildiride, ilerleyici PSMA \u2013 PET g\u00f6r\u00fcnt\u00fclemesi pozitif metastatik kastrasyona diren\u00e7li prostat kanseri (mCRPC) hastalar\u0131nda, hedefe y\u00f6nelik [&hellip;]","og_url":"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/","og_site_name":"Prof intheranostics","article_published_time":"2021-06-15T10:15:23+00:00","article_modified_time":"2021-06-16T09:39:03+00:00","og_image":[{"width":1999,"height":1333,"url":"https:\/\/www.intheranostics.com\/prof\/wp-content\/uploads\/sites\/2\/2021\/06\/Intheranostis-prof-lutesyum-177-psma-research.jpg","type":"image\/jpeg"}],"author":"faruk","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"faruk","Tahmini okuma s\u00fcresi":"2 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/","url":"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/","name":"Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00c7al\u0131\u015fmas\u0131 - Prof intheranostics","isPartOf":{"@id":"https:\/\/www.intheranostics.com\/prof\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/#primaryimage"},"image":{"@id":"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.intheranostics.com\/prof\/wp-content\/uploads\/sites\/2\/2021\/06\/Intheranostis-prof-lutesyum-177-psma-research.jpg","datePublished":"2021-06-15T10:15:23+00:00","dateModified":"2021-06-16T09:39:03+00:00","author":{"@id":"https:\/\/www.intheranostics.com\/prof\/#\/schema\/person\/38ee8a4a3a1328e80b6475667e9cb9c4"},"breadcrumb":{"@id":"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/#primaryimage","url":"https:\/\/www.intheranostics.com\/prof\/wp-content\/uploads\/sites\/2\/2021\/06\/Intheranostis-prof-lutesyum-177-psma-research.jpg","contentUrl":"https:\/\/www.intheranostics.com\/prof\/wp-content\/uploads\/sites\/2\/2021\/06\/Intheranostis-prof-lutesyum-177-psma-research.jpg","width":1999,"height":1333},{"@type":"BreadcrumbList","@id":"https:\/\/www.intheranostics.com\/prof\/blog\/lutesyum-177-psma-tedavisi-faz-iii-vision-calismasi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Ana sayfa","item":"https:\/\/www.intheranostics.com\/prof\/"},{"@type":"ListItem","position":2,"name":"Lutesyum-177 PSMA Tedavisi, Faz III VISION \u00c7al\u0131\u015fmas\u0131"}]},{"@type":"WebSite","@id":"https:\/\/www.intheranostics.com\/prof\/#website","url":"https:\/\/www.intheranostics.com\/prof\/","name":"Prof intheranostics","description":"Internal Radionuclide Diagnosis &amp; Therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.intheranostics.com\/prof\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/www.intheranostics.com\/prof\/#\/schema\/person\/38ee8a4a3a1328e80b6475667e9cb9c4","name":"faruk","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/www.intheranostics.com\/prof\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/526b11e80af0c3c187b5533b00ac60a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/526b11e80af0c3c187b5533b00ac60a0?s=96&d=mm&r=g","caption":"faruk"},"url":"https:\/\/www.intheranostics.com\/prof\/blog\/author\/faruk\/"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.intheranostics.com\/prof\/wp-json\/wp\/v2\/posts\/3305","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.intheranostics.com\/prof\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.intheranostics.com\/prof\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.intheranostics.com\/prof\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.intheranostics.com\/prof\/wp-json\/wp\/v2\/comments?post=3305"}],"version-history":[{"count":6,"href":"https:\/\/www.intheranostics.com\/prof\/wp-json\/wp\/v2\/posts\/3305\/revisions"}],"predecessor-version":[{"id":3317,"href":"https:\/\/www.intheranostics.com\/prof\/wp-json\/wp\/v2\/posts\/3305\/revisions\/3317"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.intheranostics.com\/prof\/wp-json\/wp\/v2\/media\/3322"}],"wp:attachment":[{"href":"https:\/\/www.intheranostics.com\/prof\/wp-json\/wp\/v2\/media?parent=3305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.intheranostics.com\/prof\/wp-json\/wp\/v2\/categories?post=3305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.intheranostics.com\/prof\/wp-json\/wp\/v2\/tags?post=3305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}